Raina Biosciences
- Biotech or pharma, therapeutic R&D
Raina is an MIT spinout developing the world’s leading experimentally validated generative-AI-for-mRNA platform to design superior mRNA therapeutics. The platform delivers state-of-the-art performance in mRNA sequence design across diverse therapeutic applications, including mRNA vaccines, gene editing and replacement therapies, and non-viral CAR-T cell therapies. Raina’s team has pioneered technologies at the nexus of AI and RNA, including LinearDesign, 5UTR optimizer and GEMORNA. Our mission is to accelerate drug discovery timelines and produce best-in-class RNA therapeutics for novel applications.